The MPS Society has been funding cutting-edge research into MPS, Fabry and related diseases since its inception in 1982.
To this day, the MPS Society has spent over £12 million on research projects into these conditions, to find better treatments and care. Scientific breakthroughs and new technologies offer hope for diagnoses and treatments for those affected that was unimaginable a few years ago.
The sooner we can accelerate our research and take advantage of these opportunities, the quicker we can help even more people affected by MPS, Fabry or a related disease.
We invite research applications on the theme of psychological wellbeing
The MPS Society is inviting grants for scientific or clinical research into LSD or related conditions. Following a review of its patient support, in this round of grants the society is particularly interested in receiving applications that support and/or improve the psychological wellbeing of those impacted by LSD or related conditions. While the Society will accept applications from single centres or research units, we are specifically looking for applications from applicants collaborating with other centres or units in the field.
Clinical Scientific Advisory Board (CSAC)
Our Clinical Scientific Advisory Committee (CSAC) consists of members of our Board of Trustees and the Society’s Patient Advocacy team. These members come from medical, healthcare or research backgrounds from a broad range of disciplines and perspectives who will consider research applications each year.
All proposals will be subject to a review process to ensure they meet our high standard of quality. The committee will make an informed recommendation to our Board of Trustees who hold the final decision on how we allocate research funds.
Applications for grants will be assessed on:
The importance or burden of the health or care problem being studied
What the proposed research adds to the existing body of knowledge
The improvements in health and care this research is likely to lead to
The potential impact of the research on patients, the public and people working in health and care
Whether the cost of the research is reasonable and commensurate with the work involved
The likelihood that the research design is feasible and deliverable and answers the proposed question
We will consider applications across the breadth of metabolic medicine, but of course, will focus on MPS and related disorders.
Conflicts of interest
Both the Clinical and Scientific Advisory Committee and any external reviewers are asked to declare any conflicts of interest. Those with conflicts are not permitted to discuss or provide comment on those applications.
Research grant application process
The MPS Society is inviting applications for research grants in MPS, Fabry and related diseases. The grants will be awarded for a period of between one and three years but funding in years two and three will be subject to an annual review and the charitable funds being available. Members of the MPS Society’s Clinical and Scientific Advisory Committee (CSAC) will review the grant proposals. All research grant applications must meet the MPS Society’s terms and conditions of Medical Research Grants.
Can you join the peer review panel?
We are committed to transparency and open access and applications will be sent out for peer-review. We would encourage all applicants, potential applicants or people with an interest to help us support impactful research by joining our peer review panel, if you are willing to spare a couple of hours reviewing an application please contact the peer review coordinator.
Applications for research grants are currently open. Applications will be reviews at one of the peer review committee meetings throughout the year.
In January 2020, the MPS Society awarded a grant to Professor Simon Heales of Great Ormond Street Hospital, London to employ a scientist for one year to evaluate a new piece of equipment that could significantly improve our ability to identify patients with lysosomal disorders such a MPS I, Pompe, Fabry and Gaucher Disease. The new technology, known as Digital Microfluidics, will be thoroughly tested by the Enzyme Laboratory at Great Ormond Street Hospital. Key aims of this study will be to document how robust and reliable the equipment is and how well it copes with large numbers of samples. At the end of the study, a recommendation will be made as to whether Digital Microfluidics is a suitable technique that could be used for incorporation into a newborn screening programme and/or routine diagnostics.